FDA Approves Abbott's Over-the-Counter Glucose Monitors for Diabetics and General Health

The new devices, Libre Rio and Lingo, aim to improve accessibility for glucose monitoring and overall health management.

Abbott's Libre Rio targets Type 2 diabetics who manage their condition without insulin.
Lingo is designed for health-conscious individuals looking to track and improve their metabolic health.
Both devices can be worn on the upper arm and provide real-time glucose data via smartphone apps.
The FDA's approval marks a significant step towards making glucose monitoring more accessible.
Competitors like Dexcom are also entering the OTC glucose monitoring market.